Prognostic Significance of microRNA-221/222 Expression in Cancers: Evidence from 1,204 Subjects
暂无分享,去创建一个
J. Xu | Jie Ning | G. Sun | Y. Zou | Jing Xu | Yang Jiao | Shan Liu | Fang Wang | J. Ning | Jin Wang
[1] Wei Zhang,et al. Prognostic Role of microRNA-155 in Various Carcinomas: Results from a Meta-Analysis , 2013, Disease markers.
[2] G. Sun,et al. Protective Role of Helicobacter pylori Infection in Prognosis of Gastric Cancer: Evidence from 2454 Patients with Gastric Cancer , 2013, PloS one.
[3] M. Gazouli,et al. Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance , 2013, Molecular carcinogenesis.
[4] S. Choi,et al. Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. , 2013 .
[5] Jong Y. Park,et al. miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases. , 2013, Asian journal of andrology.
[6] S. Meltzer,et al. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. , 2012, Gastroenterology.
[7] Lei Han,et al. High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma , 2012, Journal of Translational Medicine.
[8] Carlos Cordon-Cardo,et al. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer. , 2012, The American journal of pathology.
[9] John P A Ioannidis,et al. Clinical outcome prediction by microRNAs in human cancer: a systematic review. , 2012, Journal of the National Cancer Institute.
[10] C. Fan,et al. Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance , 2012, The Journal of international medical research.
[11] E. Howe,et al. The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity , 2012, Journal of Mammary Gland Biology and Neoplasia.
[12] J. Michálek,et al. MiR‐195, miR‐196b, miR‐181c, miR‐21 expression levels and O‐6‐methylguanine‐DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients , 2011, Cancer science.
[13] A. Hui,et al. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies , 2011, BMC Cancer.
[14] Xiaonan Fu,et al. Prognostic role of microRNA‐21 in various carcinomas: a systematic review and meta‐analysis , 2011, European journal of clinical investigation.
[15] E. Han,et al. Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. , 2011, Human pathology.
[16] C. Croce,et al. MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐origin , 2011, The Journal of pathology.
[17] Wen Li,et al. Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma , 2011, Molecular Biology Reports.
[18] R. Tibshirani,et al. MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP , 2011, Clinical Cancer Research.
[19] Wanjun Yu,et al. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance. , 2011, Biochemical and biophysical research communications.
[20] Maria Kafousi,et al. MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer , 2011, Cell cycle.
[21] Chengcheng Guo,et al. Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma , 2011, Disease markers.
[22] R. Govindan,et al. Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[23] Tongyu Lin,et al. Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.
[24] P. Pu,et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN , 2010, BMC Cancer.
[25] Muneesh Tewari,et al. MiR‐221 and MiR‐222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival , 2010, Genes, chromosomes & cancer.
[26] Jianjun Chen,et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. , 2010, Blood cells, molecules & diseases.
[27] K. Choy,et al. MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling , 2010, Clinical Cancer Research.
[28] Hansjuerg Alder,et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. , 2009, Cancer cell.
[29] Gian Luca Grazi,et al. MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality , 2009, Clinical Cancer Research.
[30] G. Kristiansen,et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma , 2009, International journal of cancer.
[31] C. Scholz,et al. Expression of microRNA‐221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence , 2009, International Journal of Cancer.
[32] Lu Jiang,et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. , 2009, Cancer genomics & proteomics.
[33] Tyler E. Miller,et al. MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.
[34] C. Croce,et al. MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer , 2008, Oncogene.
[35] Leonard D. Goldstein,et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.
[36] C. Croce,et al. MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. , 2007, Endocrine-related cancer.
[37] Giovanni Vanni Frajese,et al. miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.
[38] C. Benz,et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies , 2006, Molecular Cancer.
[39] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Croce,et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Matakidou,et al. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[43] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[44] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[45] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[46] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[47] B. Woolf. ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.
[48] Chen Haicha. Expression of MicroRNA-21 in gastric cancer , 2013 .
[49] G-D Zhuang. Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro , 2013 .
[50] Hao Jun-we. MiR-221 Expression Affects Invasion Potential of Human Prostate Carcinoma Cell Lines , 2012 .
[51] C. Croce,et al. miR221/222 in cancer: their role in tumor progression and response to therapy. , 2012, Current molecular medicine.
[52] F. Wang,et al. MicroRNAs as promising biomarkers for gastric cancer. , 2012, Cancer biomarkers : section A of Disease markers.
[53] H. Taubert,et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival , 2010, International journal of cancer.